SELAS GRANDE PHARMACIE DU 8 MAI 1945 : revenue, balance sheet and financial ratios

SELAS GRANDE PHARMACIE DU 8 MAI 1945 is a French company founded 23 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MARIGNANE (13700), this company of category PME shows in 2016 a revenue of 11.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS GRANDE PHARMACIE DU 8 MAI 1945 (SIREN 443785225)
Indicator 2024 2023 2022 2021 2016 2015
Revenue N/C N/C N/C N/C 11 480 337 € 12 077 896 €
Net income 371 302 € 364 905 € 1 526 071 € 792 099 € 255 736 € 188 516 €
EBITDA N/C N/C N/C N/C 594 784 € 548 732 €
Net margin N/C N/C N/C N/C 2.2% 1.6%

Revenue and income statement

In 2024, SELAS GRANDE PHARMACIE DU 8 MAI 1945 generates positive net income of 371 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2024: 189 k€ -> 371 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

371 302 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 78%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

77.834%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

40.711%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

36.7%

Solvency indicators evolution
SELAS GRANDE PHARMACIE DU 8 MAI 1945

Sector positioning

Debt ratio
77.83 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average

In 2024, the debt ratio of SELAS GRANDE PHARMACIE DU... (77.83) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
40.71% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average

In 2024, the financial autonomy of SELAS GRANDE PHARMACIE DU... (40.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 270.38. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

270.377

Liquidity indicators evolution
SELAS GRANDE PHARMACIE DU 8 MAI 1945

Sector positioning

Liquidity ratio
270.38 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent

In 2024, the liquidity ratio of SELAS GRANDE PHARMACIE DU... (270.38) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELAS GRANDE PHARMACIE DU 8 MAI 1945

Positioning of SELAS GRANDE PHARMACIE DU 8 MAI 1945 in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELAS GRANDE PHARMACIE DU 8 MAI 1945 is estimated at 5 183 650 € (range 3 609 812€ - 7 755 037€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
3609k€ 5183k€ 7755k€
5 183 650 € Range: 3 609 812€ - 7 755 037€
NAF 5 année 2024

Valuation method used

Net Income Multiple
371 302 € × 14.0x = 5 183 650 €
Range: 3 609 812€ - 7 755 038€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS GRANDE PHARMACIE DU 8 MAI 1945 with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS GRANDE PHARMACIE DU 8 MAI 1945

What is the revenue of SELAS GRANDE PHARMACIE DU 8 MAI 1945 ?

The revenue of SELAS GRANDE PHARMACIE DU 8 MAI 1945 in 2016 is 11.5 M€.

Is SELAS GRANDE PHARMACIE DU 8 MAI 1945 profitable?

Yes, SELAS GRANDE PHARMACIE DU 8 MAI 1945 generated a net profit of 371 k€ in 2024.

Where is the headquarters of SELAS GRANDE PHARMACIE DU 8 MAI 1945 ?

The headquarters of SELAS GRANDE PHARMACIE DU 8 MAI 1945 is located in MARIGNANE (13700), in the department Bouches-du-Rhone.

Where to find the tax return of SELAS GRANDE PHARMACIE DU 8 MAI 1945 ?

The tax return of SELAS GRANDE PHARMACIE DU 8 MAI 1945 is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS GRANDE PHARMACIE DU 8 MAI 1945 operate?

SELAS GRANDE PHARMACIE DU 8 MAI 1945 operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.